Akorn, Inc.’s Chairman Adopts 10b5-1 Trading Plan

Published: Sep 24, 2012

LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX), a niche specialty pharmaceutical company, today announced that its Chairman, Dr. John N. Kapoor, on his own behalf and on behalf of several trusts of which he is a trustee, have each established pre-arranged trading plans to sell a portion of their shares in the Company over a designated period for estate planning purposes. The plans were adopted in accordance with Rule 10b5-1 of the Securities and Exchange Act of 1934.

Back to news